INBIONET, acronym standing for “INfection BIOlogy Training NETwork”, at the interface between microbiology, immunology and cellular biology, aims to explore some of the most novel themes that are beginning to emerge in the mechanisms by which pathogens manipulate host defence responses. Further, it is expected that this knowledge will lead to the development of innovative therapies based on the modulation of the host-pathogen interface.

The project is funded under the Marie Curie Initial Training Network scheme (ITN) as part of the EU’s Seventh Framework Programme (FP7) and will run from the 1st of January 2013 to 31st of December 2016. During the 4-year duration of the project a total of 15 fellows will receive training in all areas of infection biology research.

The Network integrates seven academic groups internationally recognized in the fields of microbial pathogenesis, innate immunity and molecular recognition, and intensive research SME, Preclin Biosystems, a multinational pharmaceutical company, Sanofi-Aventis, and is further supported by one associated partner (ParcBit, technological part).

Outreach & News


Our latest Newsletter brings updates on first the INBIONET fellows to pass their PhD vivas, a new member of the team, recent publications and interesting reports from Sylviane Yoba, "mTOR: the multitask Protein" and  from Dr Olawale Salami,  "Seasonal Influenza vaccination".

Read more

Molecular Systems Biology Publication

INBIONET fellow Masa Ivin, along with supervisor Professor Pavel Kovarik, have co-authored article titled “Tristetraprolin binding site atlas in the macrophage transcriptome reveals a switch for inflammation resolution” In the latest edition of Molecular Systems Biology  (2016) 12, 868 .

Read more

Trinity College Dublin - INBIONET PhD success

Read more

Why search for a new treatment for flu?

Dr Fabiane Sonego's most recent report highlights the need to develop new therapies to treat the flu.

Read more